UniProt ID | NUF2_HUMAN | |
---|---|---|
UniProt AC | Q9BZD4 | |
Protein Name | Kinetochore protein Nuf2 | |
Gene Name | NUF2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 464 | |
Subcellular Localization | Nucleus. Chromosome, centromere, kinetochore. Localizes to kinetochores from late prophase to anaphase. Localizes specifically to the outer plate of the kinetochore. NDC80 is required for efficient kinetochore localization. | |
Protein Description | Acts as a component of the essential kinetochore-associated NDC80 complex, which is required for chromosome segregation and spindle checkpoint activity. [PubMed: 12438418] | |
Protein Sequence | METLSFPRYNVAEIVIHIRNKILTGADGKNLTKNDLYPNPKPEVLHMIYMRALQIVYGIRLEHFYMMPVNSEVMYPHLMEGFLPFSNLVTHLDSFLPICRVNDFETADILCPKAKRTSRFLSGIINFIHFREACRETYMEFLWQYKSSADKMQQLNAAHQEALMKLERLDSVPVEEQEEFKQLSDGIQELQQSLNQDFHQKTIVLQEGNSQKKSNISEKTKRLNELKLSVVSLKEIQESLKTKIVDSPEKLKNYKEKMKDTVQKLKNARQEVVEKYEIYGDSVDCLPSCQLEVQLYQKKIQDLSDNREKLASILKESLNLEDQIESDESELKKLKTEENSFKRLMIVKKEKLATAQFKINKKHEDVKQYKRTVIEDCNKVQEKRGAVYERVTTINQEIQKIKLGIQQLKDAAEREKLKSQEIFLNLKTALEKYHDGIEKAAEDSYAKIDEKTAELKRKMFKMST | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------METLSFPR -------CCCCCCCC | 8.84 | 22814378 | |
5 | Phosphorylation | ---METLSFPRYNVA ---CCCCCCCCCCHH | 40.39 | 24719451 | |
21 | Ubiquitination | IVIHIRNKILTGADG HHHHHHHHHHCCCCC | 29.28 | - | |
29 | Ubiquitination | ILTGADGKNLTKNDL HHCCCCCCCCCCCCC | 49.70 | 23000965 | |
33 | Ubiquitination | ADGKNLTKNDLYPNP CCCCCCCCCCCCCCC | 52.19 | 23000965 | |
37 | Phosphorylation | NLTKNDLYPNPKPEV CCCCCCCCCCCCHHH | 12.11 | 27259358 | |
57 | Phosphorylation | MRALQIVYGIRLEHF HHHHHHHHCCCCEEE | 14.41 | 24043423 | |
67 | Ubiquitination | RLEHFYMMPVNSEVM CCEEEEEEECCCHHH | 1.98 | 21963094 | |
69 | Ubiquitination | EHFYMMPVNSEVMYP EEEEEEECCCHHHCH | 7.18 | 22817900 | |
113 | Ubiquitination | TADILCPKAKRTSRF CCCCCCCCCHHHHHH | 66.59 | 21963094 | |
115 | Ubiquitination | DILCPKAKRTSRFLS CCCCCCCHHHHHHHH | 63.44 | 22817900 | |
119 | Ubiquitination | PKAKRTSRFLSGIIN CCCHHHHHHHHHHHH | 35.59 | 21963094 | |
151 | Ubiquitination | QYKSSADKMQQLNAA HHHCCHHHHHHHHHH | 38.02 | 29967540 | |
155 | Ubiquitination | SADKMQQLNAAHQEA CHHHHHHHHHHHHHH | 2.37 | 22817900 | |
165 | Ubiquitination | AHQEALMKLERLDSV HHHHHHHHHHHHCCC | 48.31 | 21906983 | |
171 | Phosphorylation | MKLERLDSVPVEEQE HHHHHHCCCCHHHHH | 32.67 | 25159151 | |
181 | Ubiquitination | VEEQEEFKQLSDGIQ HHHHHHHHHHHHHHH | 54.32 | 29967540 | |
184 | Phosphorylation | QEEFKQLSDGIQELQ HHHHHHHHHHHHHHH | 31.15 | 20873877 | |
188 | Ubiquitination | KQLSDGIQELQQSLN HHHHHHHHHHHHHHC | 51.37 | 22817900 | |
193 | Phosphorylation | GIQELQQSLNQDFHQ HHHHHHHHHCCCHHH | 19.14 | 20873877 | |
201 | Ubiquitination | LNQDFHQKTIVLQEG HCCCHHHHHHEEECC | 31.48 | 21906983 | |
210 | Phosphorylation | IVLQEGNSQKKSNIS HEEECCCCHHCCCHH | 54.99 | 25159151 | |
212 | Ubiquitination | LQEGNSQKKSNISEK EECCCCHHCCCHHHH | 58.97 | 29967540 | |
213 | Ubiquitination | QEGNSQKKSNISEKT ECCCCHHCCCHHHHH | 40.89 | - | |
234 | Ubiquitination | KLSVVSLKEIQESLK HHHEEEHHHHHHHHH | 45.31 | 22817900 | |
239 | Phosphorylation | SLKEIQESLKTKIVD EHHHHHHHHHHCCCC | 20.84 | - | |
241 | Ubiquitination | KEIQESLKTKIVDSP HHHHHHHHHCCCCCH | 57.99 | - | |
242 | Phosphorylation | EIQESLKTKIVDSPE HHHHHHHHCCCCCHH | 31.15 | 23312004 | |
243 | Ubiquitination | IQESLKTKIVDSPEK HHHHHHHCCCCCHHH | 38.86 | - | |
247 | Phosphorylation | LKTKIVDSPEKLKNY HHHCCCCCHHHHHHH | 24.86 | 29255136 | |
250 | Ubiquitination | KIVDSPEKLKNYKEK CCCCCHHHHHHHHHH | 69.05 | 29967540 | |
261 | Phosphorylation | YKEKMKDTVQKLKNA HHHHHHHHHHHHHHH | 21.22 | 17924679 | |
269 | Ubiquitination | VQKLKNARQEVVEKY HHHHHHHHHHHHHHH | 42.45 | 22817900 | |
286 | Ubiquitination | YGDSVDCLPSCQLEV CCCCCCCCCCCHHHH | 2.79 | 22817900 | |
287 | Ubiquitination | GDSVDCLPSCQLEVQ CCCCCCCCCCHHHHH | 39.11 | 22817900 | |
289 | Ubiquitination | SVDCLPSCQLEVQLY CCCCCCCCHHHHHHH | 5.17 | 22817900 | |
299 | Ubiquitination | EVQLYQKKIQDLSDN HHHHHHHHHHHCCCC | 30.03 | 29967540 | |
304 | Phosphorylation | QKKIQDLSDNREKLA HHHHHHCCCCHHHHH | 40.92 | 25999147 | |
309 | Ubiquitination | DLSDNREKLASILKE HCCCCHHHHHHHHHH | 46.22 | 29967540 | |
312 | Phosphorylation | DNREKLASILKESLN CCHHHHHHHHHHHCC | 38.60 | 24719451 | |
315 | Ubiquitination | EKLASILKESLNLED HHHHHHHHHHCCHHH | 43.52 | 21906983 | |
317 | Phosphorylation | LASILKESLNLEDQI HHHHHHHHCCHHHHH | 22.44 | 29978859 | |
326 | Phosphorylation | NLEDQIESDESELKK CHHHHHCCCHHHHHH | 48.59 | 29978859 | |
329 | Phosphorylation | DQIESDESELKKLKT HHHCCCHHHHHHHHC | 53.90 | 29978859 | |
332 | Ubiquitination | ESDESELKKLKTEEN CCCHHHHHHHHCCCC | 52.59 | 21906983 | |
333 | Ubiquitination | SDESELKKLKTEENS CCHHHHHHHHCCCCC | 68.77 | 22817900 | |
335 | Ubiquitination | ESELKKLKTEENSFK HHHHHHHHCCCCCCC | 63.87 | 22817900 | |
342 | Ubiquitination | KTEENSFKRLMIVKK HCCCCCCCCEEEEEH | 44.43 | - | |
348 | Acetylation | FKRLMIVKKEKLATA CCCEEEEEHHHHHHE | 44.27 | 24885425 | |
356 | Ubiquitination | KEKLATAQFKINKKH HHHHHHEEEECCCCC | 35.49 | 27667366 | |
358 | Ubiquitination | KLATAQFKINKKHED HHHHEEEECCCCCHH | 33.03 | 32015554 | |
363 | Ubiquitination | QFKINKKHEDVKQYK EEECCCCCHHHHHHH | 37.79 | 22817900 | |
367 | Ubiquitination | NKKHEDVKQYKRTVI CCCCHHHHHHHHHHH | 61.30 | 29967540 | |
372 | Phosphorylation | DVKQYKRTVIEDCNK HHHHHHHHHHHHHHH | 22.99 | 29052541 | |
379 | Ubiquitination | TVIEDCNKVQEKRGA HHHHHHHHHHHHHCC | 52.18 | 24816145 | |
383 | Ubiquitination | DCNKVQEKRGAVYER HHHHHHHHHCCHHHH | 38.75 | - | |
388 | Phosphorylation | QEKRGAVYERVTTIN HHHHCCHHHHHHHHH | 9.48 | 27642862 | |
400 | Ubiquitination | TINQEIQKIKLGIQQ HHHHHHHHHHHHHHH | 47.68 | - | |
401 | Ubiquitination | INQEIQKIKLGIQQL HHHHHHHHHHHHHHH | 2.26 | 27667366 | |
402 | Ubiquitination | NQEIQKIKLGIQQLK HHHHHHHHHHHHHHH | 47.93 | 27667366 | |
409 | Ubiquitination | KLGIQQLKDAAEREK HHHHHHHHHHHHHHH | 40.77 | 22817900 | |
418 | Ubiquitination | AAEREKLKSQEIFLN HHHHHHHHHHHHHHH | 62.25 | - | |
427 | Ubiquitination | QEIFLNLKTALEKYH HHHHHHHHHHHHHHH | 30.58 | 29967540 | |
432 | Ubiquitination | NLKTALEKYHDGIEK HHHHHHHHHHHHHHH | 49.05 | 29967540 | |
439 | Ubiquitination | KYHDGIEKAAEDSYA HHHHHHHHHHHHHHH | 51.48 | 29967540 | |
447 | Ubiquitination | AAEDSYAKIDEKTAE HHHHHHHCCCHHHHH | 42.32 | 27667366 | |
451 | Ubiquitination | SYAKIDEKTAELKRK HHHCCCHHHHHHHHH | 49.65 | - | |
452 | Phosphorylation | YAKIDEKTAELKRKM HHCCCHHHHHHHHHH | 24.26 | 23090842 | |
464 | Phosphorylation | RKMFKMST------- HHHHCCCC------- | 38.85 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NUF2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NUF2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NUF2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247, AND MASSSPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-261, AND MASSSPECTROMETRY. |